Xpovio (Selinexor) Side Effect Management Made Simple! Join the IMF's Dr. Joseph Mikhael to discover the latest insights on Xpovio® (Selinexor), the pioneering XPO1 inhibitor also known as Xpovio®. Learn about the evolution of Selinexor usage in myeloma treatment, unveiling practical strategies to enhance its efficacy and mitigate potential side effects. Join us as we navigate through optimal dosing, scheduling, and supportive care measures to ensure the utmost benefits for patients.
This episode of the Myeloma Made Simple Series is supported by Karyopharm Therapeutics.
_______________
Improving Lives | Finding the Cure
Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest organization focusing specifically on multiple myeloma. The IMF’s reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of lives of myeloma patients while working toward prevention and a cure through our four founding principles: Research, Education, Support, and Advocacy.
Subscribe to our channel: / imfmyeloma
Visit our website at: www.myeloma.org
Find us online:
Facebook: @myeloma | / myeloma
Twitter: @IMFMyeloma | / imfmyeloma
Instagram: @imfmyeloma | / imfmyeloma
LinkedIn: / international-myeloma-...
Support the IMF | Donate Now! fundraise.myel...
Category
Nonprofits & Activism
License
Standard KZitem License
In most cases, captions are autogenerated by KZitem.
Негізгі бет Myeloma Made Simple: Xpovio (Selinexor) Side Effect Management Made Simple | Managing Side Effects
Пікірлер: 1